Cite
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
MLA
Rajasekhar, Megha, et al. “Primaquine Dose and the Risk of Haemolysis in Patients with Uncomplicated Plasmodium Vivax Malaria: A Systematic Review and Individual Patient Data Meta-Analysis.” Lancet Infectious Diseases, vol. 24, no. 2, Feb. 2024, pp. 184–95. EBSCOhost, https://doi.org/10.1016/S1473-3099(23)00431-0.
APA
Rajasekhar, M., Simpson, J. A., Ley, B., Edler, P., Chu, C. S., Abreha, T., Awab, G. R., Baird, J. K., Bancone, G., Barber, B. E., Grigg, M. J., Hwang, J., Karunajeewa, H., Lacerda, M. V. G., Ladeia-Andrade, S., Llanos-Cuentas, A., Pukrittayakamee, S., Rijal, K. R., Saravu, K., & Sutanto, I. (2024). Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis. Lancet Infectious Diseases, 24(2), 184–195. https://doi.org/10.1016/S1473-3099(23)00431-0
Chicago
Rajasekhar, Megha, Julie A Simpson, Benedikt Ley, Peta Edler, Cindy S Chu, Tesfay Abreha, Ghulam R Awab, et al. 2024. “Primaquine Dose and the Risk of Haemolysis in Patients with Uncomplicated Plasmodium Vivax Malaria: A Systematic Review and Individual Patient Data Meta-Analysis.” Lancet Infectious Diseases 24 (2): 184–95. doi:10.1016/S1473-3099(23)00431-0.